Magic mushrooms take on PTSD: early trial begins
NCT ID NCT07275970
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This early-stage study tests whether psilocybin from whole mushrooms can safely help adults with PTSD. Up to 24 participants will eat dried mushrooms in chocolate and be monitored for side effects and symptom changes. The goal is to gather safety data and see if this approach might ease PTSD symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Scottsdale Research Institute
Scottsdale, Arizona, 85022, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can six short writing sessions ease PTSD in underserved patients?
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?
- Brain scans may guide psychedelics and magnetic pulses to quell suicidal thoughts
- Can online training equip therapists to tackle PTSD and addiction?
- A prescription app takes on PTSD: can digital therapy replace the couch?
- A new talk therapy aims to tackle both insomnia and PTSD in veterans